The EU Joint Program – Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on personalized medicine for neurodegenerative diseases.
Pre-proposals must be submitted no later than 15:00h C.E.T. on March 12, 2019.
Neurodegenerative diseases are debilitating and still largely untreatable conditions. These diseases are characterized by a large variability in their origins, mechanisms and clinical expression, requesting treatments that will need to take into account all these specificities. Deciphering this variability is one of the biggest challenges in the treatment of neurodegenerative diseases and the way forward is Precision Medicine, supported by highly personalized approaches for the greatest benefit of the patients.
In this context, in partnership with the European Commission, JPND announced today a new call, inviting multinational research teams to submit proposals for ambitious, innovative, multinational and multidisciplinary collaborative research projects to change the trajectory of these debilitating diseases through the development of Precision Medicine approaches.
JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological/molecular characteristics together with environmental and lifestyle factors.